AVAH
Aveanna Healthcare Holdings Inc.
AVAH's fundamentals are strong: revenue grew 17% and free cash flow more than doubled. At 8.7x earnings, it's trading less than half its usual 21x. Analysts expect that strong growth to continue.
AVAH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Under pressure |
AVAH's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
AVAH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $9.24 | -25% |
| Current | 8.7x | $12.24 | — |
| Forward | 14x | $12.24 | — |
| Fair | 21x | $29.51 | +141% |
| Expensive | 108x | $151 | +1130% |
Historical ranges are pointers, not guarantees.
AVAH's PE is in its cheap range at 8.7x. On analysts' estimates for next year's earnings, today's price would be 14x, in its fair range.
AVAH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for AVAH, with profitability improving.
AVAH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | -37% |
| Q3 2026 | $1.40 | +278% |
| Q2 2026 | $1.26 | +1300% |
| Q1 2026 | $1.21 | +3933% |
| Q4 2025 | $1.05 | +$1.11 |
| Q3 2025 | $0.37 | +$0.71 |
| Q2 2025 | $0.09 | +$0.75 |
| Q1 2025 | $0.03 | +$0.63 |
| Q4 2024 | -$0.06 | +$0.65 |
AVAH's earnings per share have climbed steadily: $1.40 over the past year, about four times what it earned the year before, and higher year over year for 14 quarters in a row.
AVAH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $695.5M | +12% |
| Q2 2026 | $670.5M | +14% |
| Q1 2026 | $647.9M | +16% |
| Q4 2025 | $662.5M | +27% |
| Q3 2025 | $621.9M | +22% |
| Q2 2025 | $589.6M | +17% |
| Q1 2025 | $559.2M | +14% |
| Q4 2024 | $519.9M | +8.6% |
AVAH's revenue has grown year over year for 19 quarters in a row: $696M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +3.4 points |
| Q2 2026 | 12% | -1.7 points |
| Q1 2026 | 11% | +1.4 points |
| Q4 2025 | 11% | +1.9 points |
| Q3 2025 | 8.6% | +1.9 points |
| Q2 2025 | 14% | +6.2 points |
| Q1 2025 | 9.3% | +4.6 points |
| Q4 2024 | 8.8% | +2.7 points |
AVAH's operating margin was 12% last quarter, up 3.4 points from the same quarter a year ago, near the top of its range since 2020.
AVAH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $72.2M | +118% |
| Q2 2026 | $80.9M | +57% |
| Q1 2026 | $4.3M | +$13M |
| Q4 2025 | $49.7M | +271% |
| Q3 2025 | $33.2M | +13% |
| Q2 2025 | $51.6M | +2751% |
| Q1 2025 | -$8.6M | +$3.3M |
| Q4 2024 | $13.4M | +$16.4M |
AVAH generated $207M in free cash flow over the past year, up 131% from the year before.
AVAH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +4.4M shares |
| 1 year | +3.1% | +7M shares |
| 3 years | +21% | +40.1M shares |
| 5 years | +29% | +51.5M shares |
| Available history | +27% | +49.1M shares |
AVAH has 229M diluted shares, up 3.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
AVAH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.5x | Elevated |
| Q2 2026 | 4.2x | High |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 4.1x | High |
| Q3 2025 | 4.8x | High |
| Q2 2025 | 5.3x | High |
| Q1 2025 | 6.7x | High |
| Q4 2024 | 8.0x | High |
AVAH's net debt is about 3.5 years of its operating earnings (EBITDA), down from 4.8 years a year ago.
AVAH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 69.3 | Neutral |
AVAH's weekly RSI is 58 (neutral) and its Stochastic is 69 (neutral).
AVAH PE vs Healthcare Sector
| Metric | AVAH | Sector median | Relative |
|---|---|---|---|
| PE | 8.7x | 26x | 66% below |
| PE % | 27 | 36 | 9 pts below |
AVAH is trading at 8.7x earnings, a 66% discount to the Healthcare sector's median of 26x.
AVAH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.7 | 3.6% below |
| 20 week MA | $11.9 | 2.6% above |
| 50 week MA | $9.34 | 31% above |
| 100 week MA | $7.66 | 60% above |
| 200 week MA | $5.12 | 139% above |
AVAH's trend is up, with a small recent dip: it's below only its 8-week average, and 139% above its 200-week average.
AVAH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.7 | $7.07 | -39% |
| 2022 | $7.07 | $0.77 | -89% |
| 2023 | $0.77 | $2.68 | +248% |
| 2024 | $2.68 | $4.66 | +74% |
| 2025 | $4.66 | $8.62 | +85% |
| 2026 YTD | $8.62 | $12.2 | +42% |
AVAH's yearly returns have swung widely, from +248% in 2023 to −89% in 2022. It's up 42% so far in 2026.